ONECHAIN IMMUNOTHERAPEUTICS
OneChain Immunotherapeutics is a spin-off Company from Instituto de Investigación contra la Leucemia Josep Carreras and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.
ONECHAIN IMMUNOTHERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2020-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.onechaintx.com
Total Employee:
1+
Status:
Active
Total Funding:
3.05 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag Euro
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
ImmPACT Bio
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Current Employees Featured
Founder
Investors List
Invivo Capital Partners
Invivo Capital Partners investment in Seed Round - OneChain Immunotherapeutics
Josep Carreras Leukaemia Research Institute
Josep Carreras Leukaemia Research Institute investment in Seed Round - OneChain Immunotherapeutics
Catalan Institution for Research and Advanced Studies
Catalan Institution for Research and Advanced Studies investment in Seed Round - OneChain Immunotherapeutics
Official Site Inspections
http://www.onechaintx.com
- Host name: shx814.guebs.net
- IP address: 185.23.70.117
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "OneChain Immunotherapeutics"
Board of directors - Onechaintx
Pablo Menéndez Founder and CSO. Pablo Menéndez was awarded a PhD by the University of Salamanca in 2002. He then conducted postdoctoral training (2002-2006) in stem cell biology …See details»
OneChain Immunotherapeutics - Crunchbase Company Profile
OneChain Immunotherapeutics is a spin-off Company from Instituto de Investigación contra la Leucemia Josep Carreras and ICREA, that aims to develop CAR-T candidates against …See details»
OneChain Immunotherapeutics - Overview, News & Similar
View OneChain Immunotherapeutics (www.onechaintx.com) location in Spain , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
OneChain Immunotherapeutics Company Information - Funding, …
OneChain Immunotherapeutics, based in Barcelona, specializes in developing CAR-T therapies for leukemia. This niche focus distinguishes them from traditional treatments like …See details»
OneChain Immunotherapeutics SL (OneChain …
· onechaintx.com First patient treated in OneChain Immunotherapeutics’ CAR T trial for cortical T-cell acute lymphoblastic leukemia OneChain Immunotherapeutics announces the treatment of the first patient in the …See details»
Onechain Immunotherapeutics - Company Profile - Tracxn
Mar 2, 2025 Onechain Immunotherapeutics - Developer of immunotherapies against hematological malignancies. Raised a total funding of $7.33M over 3 rounds from 5 investors. …See details»
Team - OneChain
Cristina also has more than 15 years of experience in the Financial Sector, were she worked as Senior Management Executive Assistant and as Deputy Director and Account Manager of bank office. Cristina joined OneChain …See details»
OneChain Immunotherapeutics - Invivo Partners
Jul 11, 2020 OneChain Immunotherapeutics is a spin-off company from the Josep Carreras Leukaemia Research Institute (IJC) and ICREA. The company aims to develop …See details»
OneChain Immunotherapeutics - ASEBIO
CAR-T CD1a for the treatment of T cell Acute Lymphoblastic Leukemia; Allogeneic DOTs platformSee details»
OneChain Immunotherapeutics Overview | SignalHire Company …
OneChain Immunotherapeutics is a spin-off Company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop CAR-T candidates against different …See details»
OneChain Immunotherapeutics S - Parc Científic de Barcelona
Application should be sent to the CEO ([email protected]) before 01/06/2023. Please clearly state “Process Development Director Position OCI”. The pre-selection process will be …See details»
Whistleblowing Channel - OneChain
Electronically: [email protected]. By mail to the following address: C/Baldiri Reixac, n.º 4-6, Edificio Torres R+D+I, Parc Científic de Barcelona, (08028) Barcelona – to the …See details»
OneChain Immunotherapeutics - EU-Startups
Articles about OneChain Immunotherapeutics: June 23, 2023 Weekly funding round-up! All of the European startup funding rounds we tracked this week (June 19-23) June 26, 2021 101 Top …See details»
OneChain | Legal Disclaimer
CAR-T Immunotherapies against hematological malignancies. Legal disclaimer. ONE CHAIN IMMUNOTHERAPEUTICS (hereinafter referred to as “ONE CHAIN …See details»
OneChain Immunotherapeutics
OneChain Immunotherapeutics is a clinical stage spin-off company from the Josep Carreras Leukemia Research Institute and ICREA, based on research led by Dr. Pablo Menéndez's team.See details»
Contact - OneChain
Laboratory. Parc Científic de Barcelona. Cluster II, C/Baldiri Reixac, 4-12 i 15, 08028 Barcelona. Write us an email [email protected]See details»
OneChain Immunotherapeutics Company Information - Funding, …
Get information on funding, investors, industries, and more for OneChain Immunotherapeutics. See OneChain Immunotherapeutics company profile and funding data.See details»
OneChain Immunotherapeutics S
OneChain Immunotherapeutics S.L is a clinical stage spin-off company from Fundación Josep Carreras with investment by Invivo Partners, Clave Capital, Nara Capital and CDTI-Innvierte …See details»
OneChain - EU-Startups
OneChain is a spin-off company from the Josep Carreras Leukemia Research Institute and ICREA, that aims to develop immunotherapies against hematological neoplasms using CAR-T …See details»
OneChain Immunotherapeutics participates in a consortium …
Apr 3, 2024 PR_TransMisiones_enUS_VF OCI.pdf. The Ministry of Science, Innovation and Universities in collaboration with the Center for Technological Development and Innovation …See details»